The Effect of Sevoflurane on Airway Hyperreactivity During the Perioperative Period.

NCT06694675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2025-01-22

No results posted yet for this study

Summary

To investigate the effects of sevoflurane on respiratory parameters and respiratory inflammation in healthy and RSV-infected under general anesthesia and to propose suitable perioperative airway protection measures for children with respiratory virus infection undergoing general anesthesia.

Conditions

  • RSV Infection in Children Less Than 5 Years of Age
  • General Anesthesia

Interventions

DRUG

Sevoflurane (Volatile Anesthetic)

Sevoflurane 1%\~3.5%

DRUG

propofol

Propofol 9\~15mg/kg/h

Sponsors & Collaborators

  • First Hospital of China Medical University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-08-31
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06694675 on ClinicalTrials.gov